IMA

The IMA is responsible for authorising and licensing medicinal products in the Icelandic market, monitor adverse reactions from medicinal products, authorize clinical trials, decide which medicines are eligible for reimbursement, monitor medical devices available in Iceland and supervise adverse incidents involving medical devices, regulatory surveillance of all pharmacies and pharmacy subsidiaries in Iceland.